Results

Most recent

AMD-Non-neovascular

1–10 of 32 results for AMD-Non-neovascular

Impact of Baseline OCT Characteristics on Response to Risuteganib for the Treatment of Intermediate Age-Related Macular Degeneration
Justis P. Ehlers, MD, FASRS
Annual Meeting Talks
2020
Pentosan Polysulfate Maculopathy Versus Age-Related Macular Degeneration: Comparative Assessment With Multimodal Imaging
Joseph S Christiansen, MD
Annual Meeting Talks
2020
Phase 1 Safety Study of Intravitreal (ITV) Anti-High Temperature Requirement A1 (aHtrA1), a Novel Serine Protease Inhibitor, in Patients With GA
William Z. Bridges, MD
Annual Meeting Talks
2020
Ten-Year Follow-up Data From the AREDS2 Study
Emily Y. Chew, MD
Updates from the Field
2021
Evaluating Intravitreal ANX007, a Novel C1q Inhibitor, in the Treatment of GA Secondary to AMD: The ARCHER Study
David S. Boyer, MD
Updates from the Field
2021
Natural History of Untreated Atrophic Lesions in AMD and Stargardt Disease: A Meta-analysis
Lucian V. Del Priore, MD, PhD
On Demand Cases, Courses, and Papers
2019
Prospective Longitudinal Study: Fluid Quantification From Daily Self-imaging With Home OCT in Neovascular Age-Related Macular Degeneration (NV-AMD)
Jeffrey S. Heier, MD
Updates from the Field
2021
Safety of Intravitreal Pegcetacoplan in Geographic Atrophy: Results from the Phase 3 DERBY and OAKS Trials
David S. Boyer, MD
Updates from the Field
2021
Efficacy of Intravitreal Pegcetacoplan in Geographic Atrophy: Results from the Phase 3 DERBY and OAKS Trials
Nathan C. Steinle, MD
Updates from the Field
2021
Dry AMD Symposium 2
Annual Meeting Talks
2020